Momenta Pharmaceuticals (MNTA) Dec volatility at 89, March at 121 into FDA
Tweet Send to a Friend
Momenta Pharmaceuticals (Nasdaq: MNTA) is recently up 64c to $11.30. The FDA is expected to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
